RIP3-promoter adjuvant (Dong Wha)

N/A

Report date: 2025/01/26 19:35:33
NME

Base Information

Drug NameRIP3-promoter adjuvant (Dong Wha)
Drug Alias NameDW-1018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase RIPK3 stimulants
TargetsSerine/threonine-protein kinase RIPK3
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAjou University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesDong Wha Pharm Co Ltd
Inactive CompaniesAjou University Hospital
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A